Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2023-03-23 00:00:00 ET · period of report 2023-03-21 · accession 0001209191-23-020848 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-23 | 2023-03-21+ | TYRA | Harris Todd | CEO, Dir | M - OptEx | $2.25 | +19.2K | 1.70M | +1% | +$43.3K |
| DM | 2023-03-23 | 2023-03-21+ | TYRA | Harris Todd | CEO, Dir | S - Sale+OE | $16.00 | -19.2K | 1.70M | -1% | -$307.8K |
| DM | 2023-03-23 | 2023-03-21+ | TYRA | Harris Todd | CEO, Dir | M - OptEx | $0.00 | -19.2K | 416.6K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-21 | M | A | 12,393 | $2.25 | 1,713,669 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-21 | S | D | 12,393 | $16.00 | 1,701,276 | D | — | — | |
| 3 | Common | Common Stock | 2023-03-22 | M | A | 4,043 | $2.25 | 1,705,319 | D | — | — | |
| 4 | Common | Common Stock | 2023-03-23 | M | A | 2,800 | $2.25 | 1,704,076 | D | — | — | |
| 5 | Common | Common Stock | 2023-03-23 | S | D | 2,800 | $16.00 | 1,701,276 | D | — | — | |
| 6 | Common | Common Stock | 2023-03-22 | S | D | 4,043 | $16.00 | 1,701,276 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2023-03-23 | M | D | 2,800 | $0.00 | 409,776 | D | $2.25 · — to 2031-03-09 | 2,800 Common Stock | (F2) 1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date. |
| 8 | Derivative | Stock Option (Right to Buy) | 2023-03-22 | M | D | 4,043 | $0.00 | 412,576 | D | $2.25 · — to 2031-03-09 | 4,043 Common Stock | (F2) 1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date. |
| 9 | Derivative | Stock Option (Right to Buy) | 2023-03-21 | M | D | 12,393 | $0.00 | 416,619 | D | $2.25 · — to 2031-03-09 | 12,393 Common Stock | (F2) 1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date. |